Earnings Call · Q1 FY2025·2025-05-14

Q1 25EPS -24.37%·Rev n/aQ4 24EPS +56.60%·Rev n/aQ3 24EPS -16.80%·Rev n/aQ2 24EPS +32.27%·Rev n/a⚠ consensus missing

Moleculin Biotech, Inc. MBRX

Jenene Thomas — Investor Relations

Walter Klemp — Executive/Management

Paul Waymack — Executive/Management

Jonathan Foster — Executive/Management

−7.2%1d on move date−7.3% vs SPY3d−12.1%5d−8.4%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MBRX calls or request research access.

More MBRX calls Browse calls Request research access